Grufity logo
Grufity logo
MDRX

MDRX - Allscripts Healthcare Solutions Inc Stock Price, Fair Value and News

$4.80-0.38 (-7.34%)
Market Closed as of 12 Jun 2026, 04:00 pm ET

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

MDRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MDRX Price Action

Last 7 days

-4%

Last 30 days

3.2%

Last 90 days

-0.8%

MDRX RSI Chart

MDRX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MDRX Valuation

Market Cap

519.7M

Price/Earnings (Trailing)

-1.78

Price/Sales (Trailing)

0.87

EV/EBITDA

-1.63

Price/Free Cashflow

-24.09

MDRX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

MDRX Fundamentals

MDRX Revenue

MDRX Earnings

MDRX Profitability

Free Cashflow Yield

-4.15%

MDRX Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2024622.9M602.5M598.9M594.4M
2023600.6M625.3M627.7M626.0M
2022579.6M587.0M589.0M588.0M
20211.3B1.0B806.6M577.4M
20201.6B1.6B1.5B1.5B
20191.7B1.7B1.7B1.6B
20181.6B1.7B1.7B1.7B
20171.5B1.5B1.5B1.5B
20161.4B1.4B1.5B1.5B
20151.4B1.4B1.4B1.4B
20141.4B1.4B1.4B1.4B
20131.4B1.4B1.4B1.4B
20121.5B1.5B1.5B1.4B
20111.1B1.3B1.4B1.4B
2010-704.5M922.2M1.0B
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Allscripts Healthcare Solutions Inc

MDRX
Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
 CEO
 WEBSITEhttps://veradigm.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES8000

Allscripts Healthcare Solutions Inc Frequently Asked Questions

MDRX is the stock ticker symbol of Allscripts Healthcare Solutions Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jun 12 2026, market cap of Allscripts Healthcare Solutions Inc is 519.75 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Jun 12 2026, MDRX's PE ratio (Price to Earnings) is -1.78 and Price to Sales (PS) ratio is 0.87. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MDRX PE ratio will change depending on the future growth rate expectations of investors.